Hikma Eyes Another Hybrid Injectable With Arecor

Second Agreement Using 505(b)(2) Pathway

 
• By Dean Rudge
  
Handshake
Hikma and Arecor have shaken hands on another hybrid injectable co-development agreement • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business